VTAK · Catheter Precision, Inc.
$0.49
-0.01 (-1.61%)
At close · Jul 21
Market Cap
$1.04M
Shares
2.69M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Will McGuire | CEO | $911,125 |
| Andrew Jackson | CFO | $520,701 |
| Daniel Horwood | General Counsel | $404,641 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jonathan Will McGuire | CEO | $1,656,985 |
| Andrew Jackson | CFO | $874,631 |
| Daniel Horwood | General Counsel | $667,698 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andrew Jackson | CFO | $687,573 |
| Jeffrey J. Kraws | Co-President | $517,522 |
| Daniel Horwood | General Counsel | $507,639 |
| Dean S. Irwin | CEO | $311,983 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Dean S. Irwin | CEO | $10,874,823 |
| Jeffrey J. Kraws | Co-President | $8,914,269 |